top of page

​Better Quality

of Life

for Tumor

Patients.

Innovative Tumor Therapeutics

​There is an alternative for the suffering patients promising them better Quality of Life and chances for recovery.

What we provide:

  • Novel therapeutic classes to treat cancer

  • Novel anticancer agent: CT913 in preclinical development

  • Well tolerated drug

  • Small molecule based on easily accessible chemistry

  • Novel mode of action

  • Inhibition of tumor-DNA-metabolism and blockade of DNA-repair mechanism

  • Eliciting antitumor immune response  due to chemically induced "xenogenisation" 

​

What we seek:

  • Partnership for the full development of CT913

  • Appropriate partners (pharma industries; advanced biotech; investors)

Our Innovation Approach
bottom of page